- Activity pressure is positive on the latest completed week.
2291
HKG
Week ended 07 Aug 2026
Weekly Investor Report
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. · Healthcare · Medical Devices
Latest close
11.90 HKD
-0.2%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -6.0% below the Trend Line and sits at 18.8% of its 52-week range. The latest completed week returned -0.2%, after a 16.8% four-week move. The latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal.
Setup score
33
out of 100
Latest Close
11.90 HKD
7 Aug 2026
1W Return
-0.2%
latest completed week
4W Return
16.8%
short-term follow-through
12W Return
13.4%
quarterly tape
Trend Breadth
13.5%
7 of 52 weeks active
Volume Ratio
0.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 36.63% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.2%
Latest completed week; four-week move 16.8%.
Indicator stack
7/92
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 36.63%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
51/100
23 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -6.0% below the Trend Line and sits at 18.8% of its 52-week range. The latest completed week returned -0.2%, after a 16.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0912-week average 0.03
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 16.8% over four weeks, 13.4% over 12 weeks, and -50.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year7
Trend breadth13.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.98Latest activity-pressure read.
Pressure change304.1%Four-week change in activity pressure.
Leadership-21.03Latest relative-leadership reading.
RS change34.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 23 relevant articles.
1 positive · 22 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-54.6%Distance below the 52-week high.
13-week volatility12.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher8 of 2618 weeks finished lower.
Best week+31.1%Week of 24 Jul.
Worst week-17.8%Week of 31 Jul.
Latest week-0.2%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains2
Flat weeks0
Modest losses9
Sharp losses9
Recent vol12.3%13-week weekly-return volatility.
Base vol7.3%52-week weekly-return volatility.
Up/down split14/37Count of positive and negative weeks in the 52-week window.
Average skew7.3% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorHK Healthcare
4-week rank- / 100
Group average4.4%
Trend breadth12.0%
Trend12.0%active weekly trend signals
MD32.0%positive activity pressure
RS19.0%positive relative leadership
Four-week leaders
IndustryHK Medical Devices
4-week rank1 / 28
Group average-3.0%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD7.1%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape25/100
Trend, activity pressure, participation, and risk combine to a 25/100 tape read.
Indicator analysis17/100Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.
Activity pressure 0.09; No reversal markers Next-Week ExpectancyNegative 36.63%Next-week expectancy is negative with a 36.63% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment51/100Weighted news tone is neutral across 23 relevant articles.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H Revenue Breakdown – HKEX:2291 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 11.90 HKD | -0.2% | 12.66 HKD | 18.15 HKD | 0.98 | -21.03 | 2.2M | Off |
| 31 Jul 2026 | 11.92 HKD | -17.8% | 12.82 HKD | 18.24 HKD | 0.85 | -22.84 | 5.8M | Off |
| 24 Jul 2026 | 14.51 HKD | 31.1% | 12.94 HKD | 18.33 HKD | 0.59 | -4.22 | 11.0M | Off |
| 17 Jul 2026 | 11.07 HKD | 8.6% | 12.98 HKD | 18.40 HKD | 0.13 | -26.58 | 13.6M | Off |
| 10 Jul 2026 | 10.19 HKD | -4.6% | 13.14 HKD | 18.49 HKD | -0.48 | -32.26 | 4.2M | Off |
| 3 Jul 2026 | 10.68 HKD | 7.2% | 13.33 HKD | 18.59 HKD | -0.91 | -27.42 | 1.8M | Off |
| 26 Jun 2026 | 9.96 HKD | 14.1% | 13.53 HKD | 18.68 HKD | -1.26 | -31.11 | 6.1M | Off |
| 19 Jun 2026 | 8.73 HKD | -7.2% | 13.76 HKD | 18.77 HKD | -1.48 | -43.35 | 1.7M | Off |
| 12 Jun 2026 | 9.41 HKD | -2.7% | 14.01 HKD | 18.85 HKD | -1.26 | -41.70 | 540.6K | Off |
| 5 Jun 2026 | 9.67 HKD | 0.6% | 14.30 HKD | 18.94 HKD | -1.26 | -41.53 | 929.4K | Off |
| 29 May 2026 | 9.61 HKD | -15.7% | 14.55 HKD | 19.03 HKD | -1.30 | -43.11 | 4.1M | Off |
| 22 May 2026 | 11.39 HKD | 8.6% | 14.83 HKD | 19.13 HKD | -1.36 | -34.70 | 30.3M | Off |
| 15 May 2026 | 10.49 HKD | -1.5% | 15.05 HKD | 19.21 HKD | -1.62 | -41.29 | 3.2M | Off |
| 8 May 2026 | 10.65 HKD | -2.7% | 15.33 HKD | 19.30 HKD | -1.65 | -41.95 | 1.7M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.